Holen Sie sich die Stockscreener-App
59.30
1.96%
0.975
Schlusskurs vom Vortag:
$58.32
Offen:
$58.62
24-Stunden-Volumen:
359.88K
Relative Volume:
0.39
Marktkapitalisierung:
$3.03B
Einnahmen:
$534.53M
Nettoeinkommen (Verlust:
$-11.45M
KGV:
-245.94
EPS:
-0.2411
Netto-Cashflow:
$48.28M
1W Leistung:
+5.77%
1M Leistung:
+21.40%
6M Leistung:
+103.81%
1J Leistung:
+58.48%
1-Tages-Spanne:
$57.94
$59.69
1-Wochen-Bereich:
$55.66
$59.88
52-Wochen-Spanne:
$25.36
$59.88
Atricure Inc Stock (ATRC) Company Profile
Firmenname
Atricure Inc
Sektor
Telefon
513-755-4100
Adresse
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, RMD, ALC, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
59.54 | 2.77B | 534.53M | -11.45M | 48.28M | -0.2411 |
ISRG
Intuitive Surgical Inc
|
399.42 | 130.41B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
181.54 | 48.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
224.63 | 31.49B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
65.46 | 31.92B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.00 | 28.54B | 29.14B | 1.07B | 1.05B | 1.1956 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-18 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2026-02-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-04-23 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-29 | Eingeleitet | UBS | Buy |
| 2021-08-05 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Bestätigt | Needham | Buy |
| 2020-11-06 | Bestätigt | Needham | Buy |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-24 | Bestätigt | Needham | Buy |
| 2019-08-13 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | Eingeleitet | JP Morgan | Overweight |
| 2018-10-04 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Stifel | Buy |
| 2018-06-18 | Bestätigt | Needham | Buy |
| 2018-04-27 | Bestätigt | Needham | Buy |
| 2018-01-16 | Bestätigt | Needham | Buy |
| 2017-11-02 | Bestätigt | Needham | Buy |
| 2017-07-28 | Bestätigt | Needham | Buy |
| 2017-05-30 | Fortgesetzt | Piper Jaffray | Overweight |
| 2016-06-30 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2015-10-28 | Bestätigt | Needham | Buy |
| 2015-10-06 | Bestätigt | Canaccord Genuity | Buy |
| 2015-10-06 | Bestätigt | Needham | Buy |
Alle ansehen
Atricure Inc Aktie (ATRC) Neueste Nachrichten
AtriCure Executive Stock Sale Analysis - Intellectia AI
AtriCure CTO Sells 3,657 Shares - Yahoo Finance
AtriCure CTO Salvatore Privitera sells $201,135 in shares By Investing.com - Investing.com Nigeria
AtriCure (ATRC) Chief Technical Officer Salvatore Privitera Sells 3,657 Shares - GuruFocus
Do Options Traders Know Something About AtriCure Stock We Don't? - Yahoo Finance
AtriCure CTO Salvatore Privitera sells $201,135 in shares - investing.com
AtriCure (ATRC) CTO discloses pre-set stock sale - Stock Titan
AtriCure, Inc. (ATRC) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
How Atricure Inc. (ATRC) Affects Rotational Strategy Timing - Stock Traders Daily
AtriCure (ATRC) Momentum Meets A Pricey Narrative On $47 Fair Value - simplywall.st
AtriCure CTO Privitera Sells 7,763 Shares at $52.50 Each (NASDAQ: ATRC) - Kalkine Media
AtriCure at Wells Fargo conference: growth and margins run ahead By Investing.com - Investing.com India
AtriCure CTO Salvatore Privitera Sells 7,763 Shares via 10b5-1 Trading Plan - Kalkine Media
Atricure CTO Salvatore Privitera sells $407,557 in stock By Investing.com - Investing.com South Africa
AtriCure Inc (ATRC) Chief Technical Officer Salvatore Privitera Sells 7,763 Shares - GuruFocus
Atricure CTO Salvatore Privitera sells $407,557 in stock - Investing.com
Atricure Insider Sold Shares Worth $407,558, According to a Recent SEC Filing - marketscreener.com
AtriCure (ATRC) CTO sells stock under preset plan - Stock Titan
Biotech Stocks At 52-Week HighsATTO, HALO, IKT, TVTX, ATRC - RTTNews
A Look at AtriCure Inc (ATRC) After 7.5% Gain -- GF Value $39.67 vs Price $52.59 - GuruFocus
ATRC Maintains by Needham -- Price Target Raised to $64.00 - GuruFocus
AtriCure Price Target Raised to $64.00/Share From $45.00 by Needham - Moomoo
Atricure stock hits 52-week high at $50.00 By Investing.com - Investing.com Nigeria
Atricure stock hits 52-week high at $50.00 - Investing.com
Needham raises AtriCure stock price target on trial outlook - Investing.com
Needham raises AtriCure stock price target on trial outlook By Investing.com - Investing.com Nigeria
AtriCure Inc. (ATRC) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Trading Systems Reacting to (ATRC) Volatility - Stock Traders Daily
AtriCure (ATRC) Slips 1.48% to $48.54 as Shares Navigate Key Trading RangeVolatility Skew - vinanet.vn
AtriCure Inc. (ATRC) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Atrial Fibrillation Surgery Market Companies, Size & Trends 2026-2035 - Precedence Research
ATRC Maintained Overweight by Piper Sandler -- Price Target Rais - GuruFocus
Piper Sandler raises AtriCure stock price target on quality measure By Investing.com - Investing.com Nigeria
Piper Sandler Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $60 - moomoo.com
AtriCure chief legal officer sells $458,099 in stock By Investing.com - Investing.com Nigeria
Atricure Insider Sold Shares Worth $458,099, According to a Recent SEC Filing - marketscreener.com
Atrial Fibrillation Treatment Devices Market Trends and Forecast, 2035 | Includes Profiles of Abbott, AtriCure, Boston Scientific, Johnson & Johnson, and Medtronic - Yahoo Finance
AtriCure to Participate in the 2026 Wells Fargo Health Care Conference - Yahoo Finance
BTIG raises AtriCure stock price target on new quality metric By Investing.com - Investing.com Canada
BTIG raises AtriCure stock price target on new quality metric - Investing.com
AtriCure (ATRC) Financial Results: Profit Per Share Clears Its Benchmark in the Latest Session - vinanet.vn
A Look at AtriCure Inc (ATRC) After 3.0% Gain -- GF Value $39.53 vs Price $48.98 - GuruFocus
AtriCure stock hits 52-week high at 48.47 USD By Investing.com - Investing.com Nigeria
AtriCure stock hits 52-week high at 48.47 USD - Investing.com
AtriCure Stock: Promising Cardiovascular Surgical Platform (NASDAQ:ATRC) - Seeking Alpha
Advisors Capital Management LLC Takes Position in AtriCure, Inc. $ATRC - MarketBeat
Finanzdaten der Atricure Inc-Aktie (ATRC)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):